SINGULAIR 5 MG PAED 28 TAB
Singulair is indicated in the treatment of asthma as add-on therapy in those patients with mild to moderate persistent asthma who are inadequately controlled on inhaled corticosteroids and in whom “as-needed” short-acting ß-agonists provide inadequate clinical control of asthma.